Pure Global AI
NCT06421285Not yet recruiting

Effect of Preoperative Exercise on the Prevention of Secondary Lymphedema in Breast Cancer Patients

Asan Medical CenterClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Breast Neoplasms
Drug/Device/Intervention
Aerobic exercise, Strength training, Flexibility exercise
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Asan Medical Center
Timeline & enrollment
Phase
N/A
Start date
May 27, 2024
End date
Dec 31, 2025
Enrollment
60 participants
Primary outcome

Bilateral upper limb volume,ICG lymphography

Summary

Research purpose: Lymphedema is a very common complication in breast cancer patients.
 However, since there is currently no curable treatment, it is important to prevent and reduce
 the severity of lymphedema. The purpose of this study is to evaluate whether preoperative
 exercise is effective in preventing lymphedema after surgery. For secondary outcome, the
 preventive effects of exercise on other upper extremity dysfunctions (eg. pectoralis
 tightness, Axillary web syndrome, Adhesive capsulitis), which are common in breast cancer
 patients, were assessed.

ICD-10 classifications
Malignant neoplasm of breastMalignant neoplasm of breastMalignant neoplasm: Breast, unspecifiedBenign neoplasm of breastMalignant neoplasm: Central portion of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06421285
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06421285 through Pure Global AI's free database. This phase not specified trial is sponsored by Asan Medical Center and is currently Not yet recruiting. The study focuses on Breast Neoplasms. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.